| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | 2,3-dinor Prostaglandin E1 |
|---|
| Description | PGE1 is not a major naturally occurring prostaglandin, but it is widely administered clinically for several indications including peripheral occlusive vascular disease, erectile dysfunction, and in neonatal cardiology.{22,3803} The metabolism of PGE1 is normally initiated by oxidation at C-15, resulting in 13,14-dihydro-15-keto PGE1 as the major metabolite. However, inhibition of this pathway or saturation by excess substrate could theoretically lead to enhanced production of 2,3-dinor metabolites, including 2,3-dinor PGE1. The biological activity of 2,3-dinor PGE1 has not been published. |
|---|
| Size | 25 μg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2,3-dinor PGE1 |
|---|
| Gene, Accession, CAS # | CAS: 7046-40-4 |
|---|
| Catalog # | 13120-25 |
|---|
| Price | |
|---|
| Order / More Info | 2,3-dinor Prostaglandin E1 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|